FRUQUINTINIB | FRUQUINTINIB | ATC L01EK04
ANTINEOPLASTIC TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC) INHIBITOR OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS (VEGFR)-1, -2, AND -3 | ORAL | Cmax 762 NANOMOLAR Tmax 2 HOUR VD 46 LITER PPB 95 PERCENT Cl 0.8 LITER / HOUR HT 42 HOUR SOLUBILITY 0.9 MICROGRAM PER MILLILITER AT PH 6.8 | VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS (VEGFR)-1, -2, AND -3 | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |